Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus

Early second-trimester plasma protein profiling using multiplexed isobaric tandem mass tag (TMT) labeling predicts gestational diabetes mellitus

(2015) Chun Zhao et al.   ACTA DIABETOLOGICA

Cord blood FGF21 in gestational diabetes and its relationship with postnatal growth

(2015) Ana Megia et al.   ACTA DIABETOLOGICA

Development of a simple tool to predict the risk of postpartum diabetes in women with gestational diabetes mellitus

(2015) M. Köhler et al.   ACTA DIABETOLOGICA

Use of capillary blood glucose for screening for gestational diabetes mellitus in resource-constrained settings

(2015) Balaji Bhavadharini et al.   ACTA DIABETOLOGICA

Maternal hair metabolome analysis identifies a potential marker of lipid peroxidation in gestational diabetes mellitus

(2015) Xiaoling He et al.   ACTA DIABETOLOGICA

Circulating FABP4 Is a Prognostic Biomarker in Patients With Acute Coronary Syndrome but Not in Asymptomatic IndividualsSignificance

(2015) Hans Reiser et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus

(2015) Masato Furuhashi et al.   JOURNAL OF LIPID RESEARCH

Inflammation in maternal obesity and gestational diabetes mellitus

(2015) P. Pantham et al.   PLACENTA

Increased Plasma Levels of FABP4 and PTEN Is Associated with More Severe Insulin Resistance in Women with Gestational Diabetes Mellitus

(2015) Jiang-feng Mao   MEDICAL SCIENCE MONITOR

Increasing Maternal Body Mass Index Is Associated with Systemic Inflammation in the Mother and the Activation of Distinct Placental Inflammatory Pathways1

(2014) Irving L.M.H. Aye et al.   BIOLOGY OF REPRODUCTION

Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population

(2014) Takahiro Fuseya et al.   Cardiovascular Diabetology

Circulating FABP4 is a marker of metabolic and cardiovascular risk in SLE patients

(2014) S Parra et al.   LUPUS

Fatty Acid Binding Protein-4 is expressed in the mouse placental labyrinth, yet is dispensable for placental triglyceride accumulation and fetal growth

(2014) A. Makkar et al.   PLACENTA

Adipocyte fatty acid-binding protein levels are associated with left ventricular diastolic dysfunction in morbidly obese subjects

(2014) A Baessler et al.   Nutrition & Diabetes

Fraction of Gestational Diabetes Mellitus Attributable to Overweight and Obesity by Race/Ethnicity, California, 2007–2009

(2013) Shin Y. Kim et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Adipocyte Lipid Chaperone aP2 Is a Secreted Adipokine Regulating Hepatic Glucose Production

(2013) Haiming Cao et al.   Cell Metabolism

Does Inflammation Determine Metabolic Health Status in Obese and Nonobese Adults?

(2013) Catherine M. Phillips et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Racial/ethnic differences in the prevalence of gestational diabetes mellitus and maternal overweight and obesity, by Nativity, Florida, 2004-2007

(2013) Shin Y. Kim et al.   Obesity

Endogenous peptides as risk markers to assess the development of insulin resistance

(2013) Penghua Fang et al.   PEPTIDES

Elevation of Fatty Acid-Binding Protein 4 Is Predisposed by Family History of Hypertension and Contributes to Blood Pressure Elevation

(2012) Hideki Ota et al.   AMERICAN JOURNAL OF HYPERTENSION

Activation of Placental mTOR Signaling and Amino Acid Transporters in Obese Women Giving Birth to Large Babies

(2012) Nina Jansson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Carotid intima media thickness, brachial flow mediated dilation and previous history of gestational diabetes mellitus

(2012) Hossein Fakhrzadeh et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Plasma Levels of FABP4, but not FABP3, Are Associated with Increased Risk of Diabetes

(2012) Luc Djoussé et al.   LIPIDS

Maternal Serum Fatty Acid Binding Protein 4 (FABP4) and the Development of Preeclampsia

(2011) Christina M. Scifres et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia

(2010)   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy

(2010)   DIABETES CARE

IL-6 stimulates system A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2

(2009) H. N. Jones et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia

(2009) Xuejun Shangguan et al.   CLINICA CHIMICA ACTA

Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus

(2009) P. Kleiblova et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Serum Levels of the Adipokine Adipocyte Fatty Acid-binding Protein Are Increased in Preeclampsia

(2008) M. Fasshauer et al.   AMERICAN JOURNAL OF HYPERTENSION

The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults

(2008) E J Rhee et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice

(2008) Helen N. Jones et al.   FASEB JOURNAL

Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes

(2008) Anna Cabré et al.   JOURNAL OF LIPID RESEARCH

Hyperglycemia and Adverse Pregnancy Outcomes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE